Table 4.
Parameter | STD | XH | HFD | HFD + XH | HFD + XH + CC |
---|---|---|---|---|---|
ALT (U/L) | 27.8 ± 2.6 | 25.8 ± 3.5 | 76.4 ± 5.3 ***,### | 35.2 ± 3.1 ***,###,$$$ | 81.4 ± 8.3 ***,###,&&& |
AST (U/L) | 16.6 ± 1.2 | 19.3 ± 3.2 | 88.7 ± 6.5 ***,### | 27.8 ± 2.8 **,###,$$$ | 86.1 ± 6.9 ***,###,&&& |
GGT (U/L) | 21.5 ± 2.9 | 24.3 ± 2.6 | 105.3 ± 8.9 ***,### | 38.2 ± 3 ***,###,$$$ | 99.2 ± 10.6 ***,###,&&& |
Data are presented as means ± SD for n = 8 rats/group. (**, ***): significantly differed with STD group at p < 0.05, 0.01, and 0.001, respectively; (###): significantly differed with XH-treated group at p < 0.001; ($$$): significantly differed with HFD group at p < 0.001; (&&&): significantly differed with HFD + XH group at p < 0.001. AST: aspartate aminotransferase (AST); ALT: Alanine aminotransferase; and GTT: gamma-glutamyl transpeptidase.